GlassScriptPhysician profile
Thomas C Melillo
NPI 1619085479
$3,274.41
in general payments reported to CMS, 2019-2025
26 companies · $404 in 2025
The $404 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $361 · 2020: $18.17 · 2021: $1,389 · 2022: $576 · 2023: $255 · 2024: $271 · 2025: $404.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $931.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $930.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Steelhead Surgical INC | $1,266.67 | 2019-2021 | |
| Organogenesis INC. | $456.95 | 2019-2025 | Puraply, Affinity |
| Smith+Nephew, INC. | $223.68 | 2022-2025 | Stravix Pl, Grafix Pl, Hallu Lock |
| Stryker Corporation | $210.75 | 2019-2024 | Alphavent, Iconix, Omega |
| Depuy Synthes Sales INC. | $192.42 | 2020-2025 | Na, Motoband, Va-Lcp |
| Treace Medical Concepts, INC. | $132.50 | 2022-2024 | |
| Paragon 28, INC. | $120.57 | 2023-2024 | Phantom Metatarsal Shortening, Bun-Yo-Matic |
| Medtronic Vascular, INC. | $105.34 | 2019 | |
| Bioventus LLC | $100.27 | 2021-2025 | Exogen Ultrasound Bone Healing System |
| Left Coast Surgical INC | $62.75 | 2025 | |
| Nevro Corp. | $53.45 | 2023 | Senza |
| Fusion Orthopedics USA, LLC | $36.43 | 2025 | |
| Alafair Biosciences, INC. | $32.53 | 2025 | Versawrap |
| Heron Therapeutics, INC. | $31.50 | 2021-2022 | |
| Globus Medical, INC. | $28.19 | 2025 | Senza |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $27.99 | 2022 | |
| Biocomposites INC | $26.82 | 2025 | Stimulan |
| Kci USA, INC. | $25.57 | 2022 | |
| Averitas Pharma INC. | $21.29 | 2024 | Qutenza |
| Alfasigma USA, INC. | $19.61 | 2022 | |
| Avita Medical Americas, LLC | $18.06 | 2025 | Cohealyx, Recell, Permeaderm |
| Solventum Corporation | $17.73 | 2025 | Activ.A.C. |
| Kerecis Limited | $17.62 | 2022 | |
| Orthofix Medical, INC. | $16.73 | 2022 | |
| Medtronic, INC. | $14.77 | 2024 | Venaseal |
| Paratek Pharmaceuticals, INC. | $14.22 | 2025 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Melillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.